​

ClearPoint Neuro Ownership | Who Owns ClearPoint Neuro?

OverviewRevenueFinancialsChartTranscripts

ClearPoint Neuro Ownership Summary

ClearPoint Neuro is owned by 31.10% institutional investors, 7.85% insiders, and 61.05% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.19% of CLPT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.87% of its assets in ClearPoint Neuro shares.

CLPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockClearPoint Neuro31.10%7.85%61.05%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryMedical Device Stocks37.54%10.61%51.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.04M7.19%$27.96M
Vanguard group1.77M6.21%$24.17M
Geode capital management654.35K2.30%$8.95M
Susquehanna group, llp509.16K1.85%$7.83M
State street482.65K1.71%$10.52M
Blackrock366.40K1.44%$1.97M
Lane generational340.61K1.20%$4.66M
Ubs group339.81K1.20%$4.65M
Brown advisory330.73K1.17%$7.21M
Two sigma investments, lp310.53K1.10%$6.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lane generational340.61K4.22%$4.66M
Boone capital management283.91K2.03%$6.19M
Cahill wealth management244.42K1.92%$3.76M
Cm management80.00K0.92%$1.09M
Taylor frigon capital management132.42K0.92%$1.81M
Conway capital management126.72K0.74%$1.73M
Prescott group capital management180.53K0.23%$2.47M
Epacria capital partners11.73K0.21%$255.57K
Massar capital management, lp64.00K0.18%$1.39M
Parsons capital management inc/ri147.19K0.11%$2.01M

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp509.16K0.00%358.19K
Two sigma investments, lp310.53K0.01%288.60K
Boone capital management283.91K2.03%283.91K
Vanguard group1.77M0.00%269.04K
Goldman sachs group290.34K0.00%185.24K

Top Sellers

HolderShares% AssetsChange
Blackrock366.40K--1.11M
Essex investment management---232.46K
Eam investors---211.66K
Qube research---163.01K
Awm investment company---131.43K

New Positions

HolderShares% AssetsChangeValue
Boone capital management283.91K2.03%283.91K$6.19M
Prescott group capital management180.53K0.23%180.53K$2.47M
Two sigma advisers, lp132.40K0.01%132.40K$2.88M
Ci private wealth33.33K0.00%33.33K$726.15K
Hrt financial lp30.95K0.00%30.95K$423.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Northwestern mutual wealth management-8.00
Pom investment strategies-15.00
Nisa investment advisors-20.00
Rothschild investment-40.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202583-28.45%8,840,955-11.65%312.48%36-37.93%23-14.81%
Sep 30, 20251096.86%9,875,9627.83%343.33%56-11.11%2538.89%
Jun 30, 2025102-3.77%9,154,32911.74%323.71%6214.81%18-40.00%
Mar 31, 202510612.77%8,192,6637.73%293.89%5312.77%3172.22%
Dec 31, 202473-12.05%6,265,819-8.19%223.71%32-13.51%15-28.57%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF804.25K2.87%-
Vanguard Total Stock Mkt Idx Inv808.67K2.85%-17.84K
iShares Russell 2000 ETF637.59K2.24%-
Rolnik Focus FIL500.00K1.76%-
Vanguard Institutional Extnd Mkt Idx Tr297.02K1.04%-128.57K
Fidelity Small Cap Index261.10K0.92%261.10K
iShares Russell 2000 Growth ETF227.99K0.80%-
Invesco Dorsey Wright SmallCap Momt ETF187.18K0.68%-1.34K
Fidelity Extended Market Index143.25K0.50%87.00
Vanguard Russell 2000 ETF123.86K0.44%-8.79K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 25, 2026BURNETT JOSEPH CEO and PresidentSell$302.66K
Jan 26, 2026BURNETT JOSEPH CEO and PresidentSell$45.82K
Jan 09, 2026BURNETT JOSEPH CEO and PresidentSell$322.40K
Oct 10, 2025BURNETT JOSEPH CEO and PresidentSell$182.40K
Oct 10, 2025BURNETT JOSEPH CEO and PresidentSell$466.13K

Insider Transactions Trends

DateBuySell
2026 Q1-3
2025 Q4-4
2025 Q3--
2025 Q2-4
2025 Q1--

CLPT Ownership FAQ

Who Owns ClearPoint Neuro?

ClearPoint Neuro shareholders are primarily institutional investors at 31.10%, followed by 7.85% insiders and 61.05% retail investors. The average institutional ownership in ClearPoint Neuro's industry, Medical Device Stocks, is 37.54%, which ClearPoint Neuro falls below.

Who owns the most shares of ClearPoint Neuro?

ClearPoint Neuro’s largest shareholders are Blackrock funding, inc. /de (2.04M shares, 7.19%), Vanguard group (1.77M shares, 6.21%), and Geode capital management (654.34K shares, 2.30%). Together, they hold 15.71% of ClearPoint Neuro’s total shares outstanding.

Does Blackrock own ClearPoint Neuro?

Yes, BlackRock owns 1.44% of ClearPoint Neuro, totaling 366.4K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.97M$. In the last quarter, BlackRock decreased its holdings by -1.108M shares, a -75.14% change.

Who is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested?

Lane generational is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested, with 4.22% of its assets in 340.61K ClearPoint Neuro shares, valued at 4.66M$.

Who is the top mutual fund holder of ClearPoint Neuro shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of ClearPoint Neuro shares, with 2.87% of its total shares outstanding invested in 804.25K ClearPoint Neuro shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools